Stock screener

IOVA

Conviction 94HealthcareScan · Thu, Jun 25, 2026
IOVA$4.20-1.18%
ResistanceSupportVol 14
63 bars
Vol MA14 14.76M
Mar 26Apr 14May 1May 19Jun 8Jun 25
IOVANCE BIOTHERAPEUTICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.iovance.com ↗
Price4.20
Change-1.18%
Gap-0.47%
Rel volume2.28×
Avg volume14.63M
Avg $ vol59.92M
SMA 204.06
SMA 503.82
SMA 2003.01
Price vs 50+9.87%
Price vs 200+39.68%
MA stackbullish
50/200 cross—
Supertrendup · 3.53
RSI (14)55
MACD hist0.02
MACD crossbull · 2d
Stoch %K / %D47 / 61
ADX (14)18
+DI / −DI27 / 14
RSI divergence—
MACD divergence—
ATR %+7.96%
ADR %8.47%
52w high5.41
52w low1.69
From 52w high-22.37%
Above 52w low+148.52%
New 52w highNo
SqueezeOn · 5d
Bollinger width18.40%
%B0.69
Donchian pos47.23%
Donchian high4.76
Donchian low3.70
AVWAP (52w high)3.91
vs AVWAP high+7.53%
AVWAP (52w low)3.02
vs AVWAP low+39.18%
OBV trendDown
Chaikin MF (20)-0.22
Today vs 20d2.28×
Avg vol (14d)14.76M
Avg vol (20d)14.63M
Avg $ vol (20d)59.92M
Market cap1.88B
RS 3m (vs SPY)+5.15%
RS 6m (vs SPY)+63.64%
RS line new highNo
Trend template8/8
Technical rank79.9
1 week+6.87%
1 month+2.44%
3 months+12.00%
6 months+51.08%
1 year+123.40%
YTD+66.67%
P/E-4.80
P/B2.60
P/S7.12
P/FCF-5.58
EPS-1.09
Div yield—
ROE-54.17%
ROA-42.24%
Debt/Eq—
Current3.60
EV/EBITDA-4.30
Gross margin—
Net margin-148.38%
Rev growth60.60%
EPS growth-5.05%
Price target9.80
Target upside133.33%
Analyst ratingBuy
Institutional66.99%
Ent. value1.68B
Revenue71.43M
Net income-79.05M
Gross profit—
Free cash flow-336.24M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out446.5M
Employees975
ListedWed, May 26, 2010
Free float372.08M
Float %90.3%
Short interest104.25M
Days to cover8.2d
Short volume45.4%
Squeeze score84 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.17 · 2 est
Last EPS vs est−$0.19 vs −$0.19
Last surprise0.0% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank79.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.54
Support3.33
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IOVA

All disclosures →
No recent disclosed trades by Congress in IOVA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IOVA · 6 buys · 4 sells

InsiderSideShares
Countouriotis Athena
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
Dukes Iain D.
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant180.63K
Puri Raj K.
Chief Regulatory Officer · Restricted Stock Units · 2026-06-16
Grant15K
Maynard Ryan D
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
WEISER MICHAEL
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer · Restricted Stock Units · 2026-06-05
Exercise7.81K
Vogt Frederick G
Interim CEO & General Counsel · Restricted Stock Units · 2026-06-05
Exercise15.63K
Puri Raj K.
Chief Regulatory Officer · Common Stock · 2026-06-05
Tax3.84K
BILINSKY IGOR
Chief Operating Officer · Common Stock · 2026-06-05
Exercise7.81K
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer · Common Stock · 2026-06-05
Tax3.98K

SEC filings

EDGAR filings in IOVA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.